With 55,838 new Covid-19 infections, India’s total cases surge to 77,06,946. With 702 new deaths, toll mounts to 1,16,616. Total active cases are 7,15,812 after a decrease of 24,278 in last 24 hours.
The daily positivity rate has also been maintained at less than 5 per cent over the past three days. “There are 7,15,812 active cases of coronavirus infection in the country which comprises 9.29 per cent of the total caseload,” the data stated. As many as 68,74,518 people have been recovered with 79,415 new discharges in the last hours.
In other news, India has allowed all foreign nationals as well as all OCI and PIO cardholders to travel to India via air or sea. All such persons are now allowed to travel to India for any purpose, except tourism. The MHA stated that all existing visas, barring electronic visa, Tourist Visa and Medical Visa, are being restored with an immediate effect.
The coronavirus vaccine being developed by Bharat Biotech in collaboration with the Indian Council of Medical Research (ICMR) — Covaxin, has been cleared for the third phase of clinical trials.
The Hyderabad-based vaccine maker had applied to the Drugs Controller General of India (DCGI) on October 2, seeking permission to conduct Phase 3 trials.
Japanese researchers showed that masks can offer protection from airborne coronavirus particles, but even professional-grade coverings can’t eliminate contagion risk entirely.
Scientists at the University of Tokyo built a secure chamber with mannequin heads facing each other. One head, fitted with a nebulizer, simulated coughing and expelled actual coronavirus particles. The other mimicked natural breathing, with a collection chamber for viruses coming through the airway.